The ovarian cancer drug market
Nat Rev Drug Discov
.
2017 Jul;16(7):451-452.
doi: 10.1038/nrd.2017.92.
Epub 2017 May 26.
Authors
Jennifer Bamford
1
,
Rachel M Webster
1
Affiliation
1
Decision Resources Group, 9 Appold Street, London EC2A 2AP, UK.
PMID:
28546548
DOI:
10.1038/nrd.2017.92
No abstract available
MeSH terms
Antineoplastic Agents / pharmacology*
Drug Design*
Drug Industry*
Female
Humans
Ovarian Neoplasms / drug therapy*
Ovarian Neoplasms / pathology
Substances
Antineoplastic Agents